Home › Trial NCT01050322
Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment.
- Trial IDNCT01050322
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorLatin American Cooperative Oncology Group
- Enrollment142
- Start date2009-11
- ConditionsBRMS1 · Performance Status Zero to Two for Beginning the Study · Patient With a Maximum of One Chemotherapy · Patient With Progression After Taxanes
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.